← Insider buys
KPTI

Karyopharm Therapeutics Inc. · Healthcare

EVP, Chief Dev. Officer Ran Frenkel sold $43K of Karyopharm Therapeutics Inc.

Sold$42,818
$14.83Price
2,887Shares
−6%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Thu, Feb 18. Filed Mon, Feb 22, 3:11 PM ET, during the session. Not investment advice.